A.I. Could Help Doctors Spot Hard-to-Detect Signs of Breast Cancer During Routine Screenings, a Clinical Trial Suggests
Standard testing can miss some tumors, which are later diagnosed and called interval cancers. They’re often more aggressive than screening-detected disease
